USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.

Blood
Angelo AgathanggelouTatjana Stankovic

Abstract

The role of deubiquitylase ubiquitin-specific protease 7 (USP7) in the regulation of the p53-dependent DNA damage response (DDR) pathway is well established. Whereas previous studies have mostly focused on the mechanisms underlying how USP7 directly controls p53 stability, we recently showed that USP7 modulates the stability of the DNA damage responsive E3 ubiquitin ligase RAD18. This suggests that targeting USP7 may have therapeutic potential even in tumors with defective p53 or ibrutinib resistance. To test this hypothesis, we studied the effect of USP7 inhibition in chronic lymphocytic leukemia (CLL) where the ataxia telangiectasia mutated (ATM)-p53 pathway is inactivated with relatively high frequency, leading to treatment resistance and poor clinical outcome. We demonstrate that USP7 is upregulated in CLL cells, and its loss or inhibition disrupts homologous recombination repair (HRR). Consequently, USP7 inhibition induces significant tumor-cell killing independently of ATM and p53 through the accumulation of genotoxic levels of DNA damage. Moreover, USP7 inhibition sensitized p53-defective, chemotherapy-resistant CLL cells to clinically achievable doses of HRR-inducing chemotherapeutic agents in vitro and in vivo in a mur...Continue Reading

References

Jul 1, 1993·Mutation Research·V J McKelvey-MartinA Collins
Oct 29, 1999·Genes & Development·A J PierceM Jasin
Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
Jan 2, 2003·Molecular and Cellular Biology·Satoshi TateishiMasaru Yamaizumi
Jan 6, 2004·Science·Lyubomir T VassilevEmily A Liu
Apr 1, 2004·Molecular Cell·Muyang LiWei Gu
Apr 3, 2004·Nature·Jordan M CumminsBert Vogelstein
May 1, 2004·Cell Cycle·Jordan M Cummins, Bert Vogelstein
Jan 12, 2007·Leukemia·W J ChngR Fonseca
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Belinda AustenTatjana Stankovic
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Karen Kate DavidValina Lynn Dawson
Apr 28, 2009·Nature Cell Biology·Jun HuangJunjie Chen
Apr 3, 2012·Nature Genetics·Petra SchwertmanJurgen A Marteijn
Apr 24, 2012·Chemistry & Biology·Céline ReverdyFrédéric Colland
May 2, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jung-Hoon YoonLouise Prakash
Dec 26, 2012·Proceedings of the National Academy of Sciences of the United States of America·Amy ColleranRuaidhrí J Carmody
Feb 19, 2013·Molecular Aspects of Medicine·László VirágFrancisco Javier Oliver
Mar 15, 2013·Nature Reviews. Molecular Cell Biology·Yosef Shiloh, Yael Ziv
May 29, 2013·Cell Biochemistry and Biophysics·Xavier JacqStephen P Jackson
Jun 21, 2013·The New England Journal of Medicine·John C ByrdSusan O'Brien
Jan 24, 2014·The New England Journal of Medicine·Richard R FurmanSusan M O'Brien
Apr 18, 2014·Nature Reviews. Cancer·Kathryn T BiegingLaura D Attardi
May 30, 2014·The New England Journal of Medicine·Jennifer A WoyachJohn C Byrd
Jun 3, 2014·The New England Journal of Medicine·John C ByrdUNKNOWN RESONATE Investigators
Oct 11, 2012·ACS Medicinal Chemistry Letters·Joseph WeinstockBenjamin Nicholson
Oct 24, 2014·Annual Review of Medicine·Christopher J LordAlan Ashworth
Jan 6, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jia-Bin CaiJia Fan

❮ Previous
Next ❯

Citations

May 22, 2018·Cell Biochemistry and Function·Farjana Yeasmin KhusbuHan-Chun Chen
Mar 23, 2019·Bioscience Reports·Chunxia LiuLi Zhao
Oct 13, 2018·Blood·Benjamin L Lampson, Matthew S Davids
Nov 16, 2019·Journal of Experimental & Clinical Cancer Research : CR·Yuchong PengXiong Li
Jul 27, 2018·The Journal of Experimental Medicine·Björn StolteKimberly Stegmaier
Aug 28, 2020·Frontiers in Cell and Developmental Biology·Gabrielle J VallesNicholas W Ashton
Jul 15, 2017·Blood·Deepa Sampath
May 1, 2020·Current Treatment Options in Oncology·Jérôme Paillassa, Xavier Troussard
Sep 22, 2020·MedChemComm·Xingjian LiAngelo Agathanggelou
Jul 4, 2018·Signal Transduction and Targeted Therapy·Seemana BhattacharyaMrinal K Ghosh
Sep 5, 2018·The Journal of Clinical Investigation·Dongxue SuLei Shi
Nov 27, 2020·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Qiang XueXuefeng Guang
Aug 14, 2020·Molecular Cancer Therapeutics·Yamini M OholPaul D Kassner
Aug 27, 2019·Biochimica Et Biophysica Acta. Reviews on Cancer·Ji ChengWenyi Wei
Mar 3, 2021·Journal of Veterinary Internal Medicine·Aleksandra PawlakVeronique A J Smits
Mar 22, 2019·Current Opinion in Cell Biology·Radhika RawatPanagiotis Ntziachristos
May 1, 2021·International Journal of Molecular Sciences·Choong-Sil LeeJaewhan Song
May 11, 2021·The EMBO Journal·Marilynn Chow-CastroJoshua C Saldivar
Apr 18, 2020·Journal of Medicinal Chemistry·Paul R LegerDavid J Wustrow
Aug 30, 2021·Biomarker Research·Hu LeiYingli Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.